Mylan Launches Generic Dexedrine

Dexedrine is indicated for narcolepsy and attention deficit disorder with hyperactivity
Dexedrine is indicated for narcolepsy and attention deficit disorder with hyperactivity

Mylan announced the launch of Dextroamphetamine Sulfate Extended-Release Capsules, the generic version of Amedra's Dexedrine.  

Dexedrine, a CII substance, is indicated for narcolepsy and attention deficit disorder with hyperactivity as part of a total treatment program that includes psychological, educational, social measures for patients aged 6–16 years. It is a noncatecholamine, sympathomimetic amine with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

Dextroamphetamine Sulfate Extended-Release Capsules are available as 5mg, 10mg, and 15mg strengths.

For more information call (800) RX-MYLAN or visit Mylan.com.

Loading links....